Enterococcus faecalis JCM 8902 is a bacterium that was isolated from Arterio-venous shunt site.
genome sequence 16S sequence Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:45:46 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Enterococcaceae |
| Genus Enterococcus |
| Species Enterococcus faecalis |
| Full scientific name Enterococcus faecalis (Andrewes and Horder 1906) Schleifer and Kilpper-Bälz 1984 |
| Synonyms (1) |
| 67770 | Sample typeArterio-venous shunt site |
Global distribution of 16S sequence AB690251 (>99% sequence identity) for Enterococcus from Microbeatlas 
 Aquatic Samples |
3204 |
 Soil Samples |
1959 |
 Animal Samples |
70438 |
 Plant Samples |
1154 |
| Total Samples | 76755 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|
| 66792 | 46166_A01 assembly for Enterococcus faecalis NCTC12201 | contig | GCA_900447835   | 1351.3964  | 1351 | 58.15 |  |
| 124043 | PDT000701667.1 assembly for Enterococcus faecalis NCTC 12201 | contig | GCA_015311865 | 1351 | 29.6 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 67770 | Enterococcus faecalis gene for 16S rRNA, partial sequence, strain: JCM 8902 | AB690251 | 1500 | | 1351 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Padalino G, Duggan K, Mur LAJ, Maillard JY, Brancale A, Hoffmann KF. | Microbiologyopen | 10.1002/mbo3.70011 | 2024 | | |
| Vancomycin-resistant enterococci utilise antibiotic-enriched nutrients for intestinal colonisation. | King OG, Yip AYG, Horrocks V, Miguens Blanco J, Marchesi JR, Mullish BH, Clarke TB, McDonald JAK. | Nat Commun | 10.1038/s41467-025-61731-z | 2025 | | |
| Antimicrobial Activity of Silver-Containing Surgical Dressings in an In vitro Direct Inoculation Simulated Wound Fluid Model Against a Range of Gram-Positive and Gram-Negative Bacteria. | Meredith K, Forbes LE. | Surg Infect (Larchmt) | 10.1089/sur.2023.155 | 2023 | | |
| Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion Tityus trinitatis with Potent Activity against ESKAPE Pathogens and Clostridioides difficile. | Mechkarska M, Cunning TS, Taggart MG, Ternan NG, Leprince J, Coquet L, Jouenne T, Tena-Garces J, Calvete JJ, Conlon JM. | Antibiotics (Basel) | 10.3390/antibiotics12091404 | 2023 | | |
| Development of A Rapid, Low-Cost Portable Detection Assay for Enterococci in Wastewater and Environmental Waters. | Batra AR, Cottam D, Lepesteur M, Dexter C, Zuccala K, Martino C, Khudur L, Daniel V, Ball AS, Soni SK. | Microorganisms | 10.3390/microorganisms11020381 | 2023 | | |
| Silver-doped phosphate coacervates to inhibit pathogenic bacteria associated with wound infections: an in vitro study. | Nikolaou A, Felipe-Sotelo M, Dorey R, Gutierrez-Merino J, Carta D. | Sci Rep | 10.1038/s41598-022-13375-y | 2022 | | |
| Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water. | Hricova K, Roderova M, Frycak P, Pauk V, Kurka O, Mezerova K, Stosova T, Bardon J, Milde D, Kucova P, Kolar M. | Life (Basel) | 10.3390/life11121403 | 2021 | | |
| Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri. | Szemraj M, Lisiecki P, Glajzner P, Szewczyk EM. | Braz J Microbiol | 10.1007/s42770-022-00870-7 | 2023 | | |
| Evaluation and comparison of recombinase polymerase amplification coupled with lateral-flow bioassay for Escherichia coli O157:H7 detection using diifeerent genes. | Rani A, Ravindran VB, Surapaneni A, Shahsavari E, Haleyur N, Mantri N, Ball AS. | Sci Rep | 10.1038/s41598-021-81312-6 | 2021 | | |
| Antibiotic Resistance in Nosocomial Bacteria Isolated from Infected Wounds of Hospitalized Patients in Czech Republic. | Kolar M, Cermak P, Hobzova L, Bogdanova K, Neradova K, Mlynarcik P, Bostik P. | Antibiotics (Basel) | 10.3390/antibiotics9060342 | 2020 | | |
| Strategies to Improve the Potency of Oxazolidinones towards Bacterial Biofilms. | Ndukwe ARN, Wiedbrauk S, Boase NRB, Fairfull-Smith KE. | Chem Asian J | 10.1002/asia.202200201 | 2022 | | |
| Synergy between Winter Flounder antimicrobial peptides. | Clarke M, Hind CK, Ferguson PM, Manzo G, Mistry B, Yue B, Romanopulos J, Clifford M, Bui TT, Drake AF, Lorenz CD, Sutton JM, Mason AJ. | NPJ Antimicrob Resist | 10.1038/s44259-023-00010-7 | 2023 | | |
| Synthesis and Biological Studies of Benzo[b]furan Derivatives: A Review from 2011 to 2022. | Arce-Ramos L, Castillo JC, Becerra D. | Pharmaceuticals (Basel) | 10.3390/ph16091265 | 2023 | | |
| A Comprehensive Review of Aminochalcones. | Irfan R, Mousavi S, Alazmi M, Saleem RSZ. | Molecules | 10.3390/molecules25225381 | 2020 | | |
| In Vitro Efficacy of Antibiotics Released from Calcium Sulfate Bone Void Filler Beads. | Laycock PA, Cooper JJ, Howlin RP, Delury C, Aiken S, Stoodley P. | Materials (Basel) | 10.3390/ma11112265 | 2018 | | |
| Bolaamphiphile Analogues of 12-bis-THA Cl2 Are Potent Antimicrobial Therapeutics with Distinct Mechanisms of Action against Bacterial, Mycobacterial, and Fungal Pathogens. | Di Blasio S, Clarke M, Hind CK, Asai M, Laurence L, Benvenuti A, Hassan M, Semenya D, Man DK, Horrocks V, Manzo G, Van Der Lith S, Lam C, Gentile E, Annette C, Bosse J, Li Y, Panaretou B, Langford PR, Robertson BD, Lam JKW, Sutton JM, McArthur M, Mason AJ. | mSphere | 10.1128/msphere.00508-22 | 2023 | | |
| Pathogenicity | Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species. | Eerdunbayaer, Orabi MA, Aoyama H, Kuroda T, Hatano T. | Molecules | 10.3390/molecules19043883 | 2014 | |
| Pathogenicity | Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities. | Manzo G, Ferguson PM, Hind CK, Clifford M, Gustilo VB, Ali H, Bansal SS, Bui TT, Drake AF, Atkinson RA, Sutton JM, Lorenz CD, Phoenix DA, Mason AJ. | Sci Rep | 10.1038/s41598-019-47327-w | 2019 | |
| Metabolism | Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity. | Manzo G, Ferguson PM, Gustilo VB, Hind CK, Clifford M, Bui TT, Drake AF, Atkinson RA, Sutton JM, Batoni G, Lorenz CD, Phoenix DA, Mason AJ. | Sci Rep | 10.1038/s41598-018-37630-3 | 2019 | |
| Design, Synthesis and Microbiological Evaluation of Novel Compounds as Potential Staphylococcus aureus Phenylalanine tRNA Synthetase Inhibitors. | Elbaramawi SS, Hughes C, Richards J, Gupta A, Ibrahim SM, Lashine EM, El-Sadek ME, O'Neill AJ, Wootton M, Bullard JM, Simons C. | Egypt J Chem | 10.21608/ejchem.2018.4070.1357 | 2018 | | |
| Pathogenicity | Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. | Percival SL, Bowler PG, Dolman J. | Int Wound J | 10.1111/j.1742-481x.2007.00296.x | 2007 | |
| A review of the current place of glycopeptides in turkish medical practice. | Erdem H, Oncul O. | Curr Ther Res Clin Exp | 10.1016/j.curtheres.2007.03.001 | 2007 | | |
| Pathogenicity | Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. | Huycke MM, Sahm DF, Gilmore MS. | Emerg Infect Dis | 10.3201/eid0402.980211 | 1998 | |
| Enzymology | Resistant enterococci--mechanisms, laboratory detection and control in hospitals. | Wade JJ, Uttley AH. | J Clin Pathol | 10.1136/jcp.49.9.700 | 1996 | |
| Pathogenicity | A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. | Wang M, Firrman J, Liu L, Yam K. | Biomed Res Int | 10.1155/2019/7010467 | 2019 | |
| Pathogenicity | Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria. | Malanoski G, Collins L, Eliopoulos CT, Moellering RC, Eliopoulos GM. | Antimicrob Agents Chemother | 10.1128/aac.39.4.990 | 1995 | |
| Pathogenicity | Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. | Wegener HC, Aarestrup FM, Jensen LB, Hammerum AM, Bager F. | Emerg Infect Dis | 10.3201/eid0503.990303 | 1999 | |
| Pathogenicity | Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. | Miele A, Bandera M, Goldstein BP. | Antimicrob Agents Chemother | 10.1128/aac.39.8.1772 | 1995 | |
| Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana? | Cookson B. | J Clin Pathol | 10.1136/jcp.53.1.66 | 2000 | | |
| The new threats of Gram positive pathogens: re-emergence of things past. | Howe RA, Brown NM, Spencer RC. | J Clin Pathol | 10.1136/jcp.49.6.444 | 1996 | | |
| Pathogenicity | Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. | Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P. | Antimicrob Agents Chemother | 10.1128/aac.34.10.1875 | 1990 | |
| Genetics and mechanisms of glycopeptide resistance in enterococci. | Arthur M, Courvalin P. | Antimicrob Agents Chemother | 10.1128/aac.37.8.1563 | 1993 | | |
| Metabolism | Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. | Milewski WM, Boyle-Vavra S, Moreira B, Ebert CC, Daum RS. | Antimicrob Agents Chemother | 10.1128/aac.40.1.166 | 1996 | |
| Metabolism | Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. | Arthur M, Molinas C, Depardieu F, Courvalin P. | J Bacteriol | 10.1128/jb.175.1.117-127.1993 | 1993 | |
| Metabolism | Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. | Shlaes DM, Shlaes JH, Vincent S, Etter L, Fey PD, Goering RV. | Antimicrob Agents Chemother | 10.1128/aac.37.11.2432 | 1993 | |
| Pathogenicity | Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. | Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RD. | Antimicrob Agents Chemother | 10.1128/aac.40.9.2194 | 1996 | |
| Pathogenicity | In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. | Biavasco F, Lupidi R, Varaldo PE. | Antimicrob Agents Chemother | 10.1128/aac.36.2.331 | 1992 | |
| Pathogenicity | Penicillin-binding proteins and bacterial resistance to beta-lactams. | Georgopapadakou NH. | Antimicrob Agents Chemother | 10.1128/aac.37.10.2045 | 1993 | |
| Pathogenicity | Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. | Chambers HF. | Clin Microbiol Rev | 10.1128/cmr.10.4.781 | 1997 | |
| Pathogenicity | Structures of new phenolics isolated from licorice, and the effectiveness of licorice phenolics on vancomycin-resistant Enterococci. | Eerdunbayaer, Orabi MA, Aoyama H, Kuroda T, Hatano T | Molecules | 10.3390/molecules190913027 | 2014 | |
| Pathogenicity | In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis. | Nomura S, Hanaki H, Furukawa T, Unemi N | Chemotherapy | 10.1159/000239476 | 1996 | |
| Pathogenicity | Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. | Noble WC, Virani Z, Cree RG | FEMS Microbiol Lett | 10.1016/0378-1097(92)90528-v | 1992 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive165965.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License